Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.
Rogers
S A
SA
Gastrointestinal Unit, Massachusetts General Hospital, Boston 02114.
Podolsky
D K
DK
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D001650:Bile Duct Neoplasms / Q000175:diagnosis* / Q000209:etiology; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000175:diagnosis* / Q000209:etiology; D015209:Cholangitis, Sclerosing / Q000150:complications*; D006801:Humans
D015295:Antigens, Tumor-Associated, Carbohydrate